Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Príomhchruthaitheoirí: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
1984
|
Míreanna comhchosúla
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
de réir: Bowen, D, et al.
Foilsithe / Cruthaithe: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
de réir: Wilcock, G, et al.
Foilsithe / Cruthaithe: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
de réir: Emma Barrett, et al.
Foilsithe / Cruthaithe: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
de réir: Hunter White, et al.
Foilsithe / Cruthaithe: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
de réir: Marianna Yanike, et al.
Foilsithe / Cruthaithe: (2014-11-01)